Ulisse Biomed SpA (MIL:UBM) LT-Debt-to-Total-Asset : 0.01 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ulisse Biomed SpA LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Ulisse Biomed SpA's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.01.

Ulisse Biomed SpA's long-term debt to total assets ratio increased from Dec. 2023 (0.00) to Dec. 2024 (0.01). It may suggest that Ulisse Biomed SpA is progressively becoming more dependent on debt to grow their business.

Ulisse Biomed SpA LT-Debt-to-Total-Asset Historical Data

The historical data trend for Ulisse Biomed SpA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ulisse Biomed SpA LT-Debt-to-Total-Asset Chart

Ulisse Biomed SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Ulisse Biomed SpA Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial						-	0.01	-	0.02	0.01

Ulisse Biomed SpA LT-Debt-to-Total-Asset Calculation

Ulisse Biomed SpA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	0.334	/	27.259
	=	0.01

Ulisse Biomed SpA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	0.334	/	27.259
	=	0.01

Ulisse Biomed SpA (MIL:UBM) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Ulisse Biomed SpA LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Ulisse Biomed SpA's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Ulisse Biomed SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ulisse Biomed SpA (MIL:UBM) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Area Science Park - SS14 km.163, 5, Basovizza, ITA, 34149

Website

https://www.ulissebiomed.com

Ulisse Biomed SpA is a healthcare biotech company. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions. The company has three technology platforms, namely, Sagitta for molecular diagnostics, NanoHybrid for theranostics and diagnostics, and Aptavir for therapeutics.

Ulisse Biomed SpA Headlines

No Headlines